Metabolic Testing Global Market Report 2025

The metabolic testing market size has grown strongly in recent years. It will grow from $0.59 billion in 2024 to $0.64 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth during the historic period can be attributed to an increasingly health-conscious population, rising awareness of health and wellness, improvements in healthcare infrastructure, a growing number of bariatric surgery procedures, and the expansion of corporate wellness programs.

The metabolic testing market size is expected to see strong growth in the next few years. It will grow to $0.86 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth during the forecast period can be attributed to a growing emphasis on preventive healthcare, increasing demand for fitness and wellness apps, government initiatives supporting metabolic health, the expansion of wearable health devices, and rising obesity rates. Key trends in the forecast period include the integration of AI in metabolic testing, the rise of at-home testing devices, the development of portable metabolic analyzers, advancements in indirect calorimetry devices, and the emergence of IoT-enabled metabolic testing systems.

The increasing prevalence of chronic diseases is expected to drive growth in the metabolic testing market. Chronic diseases are long-term conditions that persist for a year or more, often requiring ongoing medical attention or limiting daily activities. The rise in chronic diseases is attributed to unhealthy lifestyles, poor dietary habits, and an aging population. Metabolic testing plays a vital role in managing these conditions by providing insights into an individual's metabolic health, enabling early detection of diabetes, cardiovascular diseases, and metabolic syndrome. This facilitates personalized treatment plans and improves overall disease management. For example, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, chronic diseases were responsible for 41 million deaths worldwide in 2023, accounting for 74% of global fatalities. This includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2 million from diabetes. As a result, the growing prevalence of chronic diseases is fueling the expansion of the metabolic testing market.

Leading companies in the metabolic testing market are focusing on technological advancements, such as metabolic analyzers, to enhance real-time metabolic analysis and improve research accuracy. A metabolic analyzer is a medical device that measures an individual's metabolic rate and assesses metabolic functions. It evaluates oxygen utilization, energy conversion, calorie expenditure, fuel usage (carbohydrates vs. fats), and respiratory efficiency. For instance, in September 2024, PHC Corporation, a Japan-based healthcare solutions company, launched LiCellMo, a live cell metabolic analyzer designed for real-time visualization of cellular metabolism in cell and gene therapy research. LiCellMo offers unique features such as continuous, non-invasive monitoring of glucose and lactate concentrations in cell cultures, allowing researchers to observe metabolic changes without disrupting experiments and providing a comprehensive view of cellular activity.

In September 2024, Oura, a Finland-based health technology company, acquired Veri to expand its metabolic health tracking capabilities. Through this acquisition, Oura aims to integrate metabolic health insights, including meal timing and blood sugar analysis, into the Oura app. This integration will provide users with a more holistic view of their overall health. Veri is a Finland-based company specializing in blood sugar monitoring systems that involve metabolic testing.

Major players in the metabolic testing market are Becton, Dickinson and Company, Lumen Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Agilent TechnologiesInc., Vyaire Medical Inc., Microlife Medical Home Solutions Inc., Centogene N.V., MGC Diagnostics Corporation, Geratherm Medical AG, Actofit Wearables, COSMED Srl, Levels Health Inc, Lilac Insights Pvt Ltd, CapitalBio Technology Co Ltd., Cortex Biophysik GmbH, KORR Medical Technologies Inc., AEI Technologies Inc., iWorx Systems Inc., myLAB Box Inc.

North America was the dominant region in the metabolic testing market in 2024. Asia-Pacific is expected to be the exponential growth region in the forecast period. The regions covered in metabolic testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the metabolic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Metabolic testing encompasses a series of medical tests designed to measure the body's metabolic rate, including its efficiency in converting food into energy and assessing various metabolic processes. These tests help evaluate risk factors for obesity, diabetes, and cardiovascular diseases.

The primary types of metabolic testing include body composition analyzers, cardiopulmonary exercise testing (CPET) systems, electrocardiogram (ECG) systems, metabolic carts, and other equipment. Body composition analyzers are devices that measure the proportion of fat, muscle, and bone in the body to assess overall health and fitness. These tests utilize various technologies, including VO₂ max analysis, resting metabolic rate (RMR) analysis, and body composition analysis. The applications span critical care, lifestyle disease management, and other areas, with end users including hospitals and clinics, sports training centers, and other healthcare facilities.

The metabolic testing market research report is one of a series of new reports that provides metabolic testing market statistics, including metabolic testing industry global market size, regional shares, competitors with a metabolic testing market share, detailed metabolic testing market segments, market trends and opportunities, and any further data you may need to thrive in the metabolic testing industry. This metabolic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The metabolic testing market consists of revenues earned by entities through services such as measuring resting metabolic rate (RMR), analyzing body composition, assessing caloric needs, weight management, and fitness optimization. The market value includes the value of related goods sold by the service provider or included within the service offering. The metabolic testing market also includes sales of metabolic analyzers, calorimeters, indirect calorimetry systems, and wearable metabolic tracking devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.